Literature DB >> 28453716

Inflated medicine prices in Vietnam: a qualitative study.

Tuan Anh Nguyen1, Rosemary Knight2, Andrea Mant2, Husna Razee2, Geoffrey Brooks3, Thu Ha Dang4, Elizabeth Ellen Roughead1.   

Abstract

One third of the world's population lacks regular access to essential medicines partly because of the high cost of medicines. In Vietnam, the cost to patients of medicines was 47 times the international reference price for originator brands and 11 times the price for generic equivalents in the public sector. In this article, we report the results of a qualitative study conducted to identify the principal reasons for inflated medicine prices in Vietnam.Between April 2008 and December 2009, 29 semi-structured interviews were conducted with staff from pharmaceutical companies, private pharmacies, the Ministry of Health, and the Ministry of Finance of Vietnam. Study participants were recruited using a combination of purposive and snowball sampling techniques. Interviews were recorded, transcribed and coded using NVivo8® software and analyzed using a framework of structure-conduct-performance (SCP).Participants attributed high prices of originator medicines to a monopoly of supply. The prices of generic medicines were also considered to be excessive, reportedly due to the need to recoup the cost of financial inducements paid to prescribers and procurement officers. These inducements constituted a dominant cost component of the end price of generic medicines. Poor market intelligence about current world prices, as well as failure to achieve economies of scale because of unwarranted duplication in pharmaceutical production and distribution system were also factors contributing to high prices. This was reported to be further compounded by multiple layers in the supply chain and unregulated retail mark-ups.To address these problems a multifaceted approach is needed encompassing policy and legislative responses. Policy options include establishing effective monitoring of medicine quality assurance, procurement, distribution and use. Rationalization of the domestic pharmaceutical production and distribution system to achieve economies of scale is also required. Appropriate legal responses include collaborations with the justice and law enforcement sectors to enforce existing laws.
© The Author 2017. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Informal payments; Medicine prices; Qualitative; Vietnam

Mesh:

Substances:

Year:  2017        PMID: 28453716     DOI: 10.1093/heapol/czw174

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  5 in total

1.  Corruption practices in drug prescribing in Vietnam - an analysis based on qualitative interviews.

Authors:  Tuan A Nguyen; Rosemary Knight; Andrea Mant; Husna Razee; Geoffrey Brooks; Thu H Dang; Elizabeth E Roughead
Journal:  BMC Health Serv Res       Date:  2018-07-28       Impact factor: 2.655

2.  Purchase and use of antimicrobials in the hospital sector of Vietnam, a lower middle-income country with an emerging pharmaceuticals market.

Authors:  Vu Quoc Dat; Phan Khanh Toan; H Rogier van Doorn; C Louise Thwaites; Behzad Nadjm
Journal:  PLoS One       Date:  2020-10-20       Impact factor: 3.240

3.  Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future.

Authors:  Brian Godman; Mainul Haque; Salequl Islam; Samiul Iqbal; Umme Laila Urmi; Zubair Mahmood Kamal; Shahriar Ahmed Shuvo; Aminur Rahman; Mustafa Kamal; Monami Haque; Iffat Jahan; Md Zakirul Islam; Mohammad Monir Hossain; Santosh Kumar; Jaykaran Charan; Rohan Bhatt; Siddhartha Dutta; Jha Pallavi Abhayanand; Yesh Sharma; Zikria Saleem; Thuy Nguyen Thi Phuong; Hye-Young Kwon; Amanj Kurdi; Janney Wale; Israel Sefah
Journal:  Front Public Health       Date:  2020-12-14

4.  Availability, prices and affordability of essential medicines: A cross-sectional survey in Hanam province, Vietnam.

Authors:  Huong Thi Thanh Nguyen; Dai Xuan Dinh; Trung Duc Nguyen; Van Minh Nguyen
Journal:  PLoS One       Date:  2021-11-18       Impact factor: 3.240

5.  Factors affecting healthcare pathways for chronic lung disease management in Vietnam: a qualitative study on patients' perspectives.

Authors:  Thu-Anh Nguyen; Yen Ngoc Pham; Nhung Phuong Doan; Thao Huong Nguyen; Toan Thanh Do; Giap Van Vu; Guy B Marks; Shannon McKinn; Joel Negin; Sarah Bernays; Greg J Fox
Journal:  BMC Public Health       Date:  2021-06-15       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.